Adjuvant Treatment, Peptide Vaccine Do Not Improve Melanoma Survival

Adjuvant treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) and peptide vaccine does not improve survival in patients with high-risk melanoma, researchers report.